| Last Name | Organization | Clinical Trials | State / Region | Country |
|---|---|---|---|---|
| Eugenio Zapata-Aldana | London Health Science Centre | Canada | ||
| Andrea Swenson
Principal Investigator |
University of Iowa | Iowa | United States | |
| Kara Steijlen
Principal Investigator |
Henry Ford Hospital | Michigan | United States | |
| Zachary Simmons
Principal Investigator |
Penn State Hershey Medical Center | Pennsylvania | United States | |
| Jennifer Roan | United States | |||
| Patricia Riley | CSL Behring | MG-SCIg (ends 2022) | Minnesota | United States |
| Colin Quinn
|
Select a Country | |||
| Richard Nowak
Principal Investigator |
Yale University School of Medicine | EPITOME II (ends 2020) | Connecticut | United States |
| Nataly Montes-Chinea | United States | |||
| Margherita Milone | Mayo Clinic | Minnesota | United States | |
| Janice Massey
|
Select a Country | |||
| Veronica Martin
Study Coordinator |
University of California, Irvine | Methotrexa (ends 2019), Rasagiline (ends 2021) | California | United States |
| Jean Mah
|
Select a Country | |||
| Jau-Shin Lou
Principal Investigator |
Sanford Health | North Dakota | United States | |
| Chamindra Konersman | University of California, San Diego | California | United States | |
| Chafic Karam
Principal Investigator |
Oregon health science university | Rasagiline (ends 2021) | Oregon | United States |
| Yessar Hussain
Principal Investigator |
Austin Neuromuscular Center | Rasagiline (ends 2021), n/a | Texas | United States |
| James Howard
Principal Investigator |
University of North Carolina at Chapel Hill | FOR-DMD (ends 2024), Methotrexa (ends 2019) | North Carolina | United States |
| Michael Hehir
Principal Investigator |
University of Vermont Larner College of Medicine | EPITOME I (ends 2018) | Vermont | United States |
| Neelam Goyal
Principal Investigator |
Stanford University | California | United States |
